J&Jâs nasal spray to treat major depressive disorder gets FDA nod
The US Food and Drug Administration has approved Johnson & Johnsonâs nasal spray in adults who have had an inadequate response to at
The US, the World Health Organizationâs top donor, has decided to withdraw from the global health body, accusing it of âmishandlingâ the Covid-19
HQ Team January 20, 2024:People with fat stored within their muscles, known as intermuscular fat, face a significantly higher risk of serious cardiovascular
HQ Team January 20, 2025: Research has unveiled 293 new gene variants linked to major depressive disorder (MDD), significantly enhancing our understanding of
HQ Team January 19, 2025: A study led by researchers from the Broad Institute, Harvard Medical School, and McLean Hospital has shed light
AstraZeneca Plc.âs antibody-drug conjugate for treating a certain type of breast cancer got approval from the US drug regulator, the company stated.
HQ Team January 17, 2025: The commonly prescribed sleep medications, particularly zolpidem, known by its brand name Ambien, may disrupt the brain’s natural
HQ Team January 17, 2025: A study has found a significant association between the use of hormonal contraceptives and an increased risk of